Pfizer’s pill cuts COVID deaths and hospitalisations by 90%
pharmaphorum
NOVEMBER 5, 2021
An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or death from COVID-19 when given in the early stages of infection. When the drug was given within three days of symptom onset, 0.8%
Let's personalize your content